93 related articles for article (PubMed ID: 2517007)
1. [Efficacy and acceptability of rilmenidine in mild to moderate arterial hypertension. A multicenter, randomized, double-blind trial, in comparison with methyldopa in 157 patients].
Wilkinson R; Mansy S; Corcoran C
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():31-8. PubMed ID: 2517007
[TBL] [Abstract][Full Text] [Related]
2. [Multicenter, double-blind study comparing rilmenidine 1 mg and hydrochlorothiazide 25 mg in 244 patients].
Fiorentini C; Guillet C; Guazzi M
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():39-46. PubMed ID: 2517008
[TBL] [Abstract][Full Text] [Related]
3. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].
Dallocchio M; Gosse P; Fillastre JP; Grollier G; Morand P; Drici M; Corcoran C
Presse Med; 1991 Aug 31-Sep 7; 20(27):1265-71. PubMed ID: 1832761
[TBL] [Abstract][Full Text] [Related]
4. The effects of two centrally-acting anti-hypertensive drugs on the quality of life.
Fletcher AE; Beevers DG; Dollery CT; Wilkinson R; Bulpitt CJ
Eur J Clin Pharmacol; 1991; 41(5):397-400. PubMed ID: 1684749
[TBL] [Abstract][Full Text] [Related]
5. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients.
Fillastre JP; Letac B; Galinier F; Le Bihan G; Schwartz J
Am J Cardiol; 1988 Feb; 61(7):81D-85D. PubMed ID: 2894165
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive efficacy and acceptability of rilmenidine in elderly hypertensive patients.
Galley P; Manciet G; Hessel JL; Michel JP
Am J Cardiol; 1988 Feb; 61(7):86D-90D. PubMed ID: 2894166
[TBL] [Abstract][Full Text] [Related]
7. [Effects of rilmenidine on the central nervous system and kidney].
Fillastre JP
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
[TBL] [Abstract][Full Text] [Related]
8. Rilmenidine: a novel approach to first-line treatment of hypertension.
Laurent S; Safar M
Am J Hypertens; 1992 Apr; 5(4 Pt 2):99S-105S. PubMed ID: 1350733
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and acceptability of rilmenidine for mild to moderate systemic hypertension.
Ostermann G; Brisgand B; Schmitt J; Fillastre JP
Am J Cardiol; 1988 Feb; 61(7):76D-80D. PubMed ID: 2894164
[TBL] [Abstract][Full Text] [Related]
10. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
Scemama M; Février B; Beucler I; Dairou F
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S34-9. PubMed ID: 8642803
[TBL] [Abstract][Full Text] [Related]
11. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
12. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
Scemama M; Février B; Beucler I; Dairou F
Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
[TBL] [Abstract][Full Text] [Related]
13. [Effects of rilmenidine on arterial parameters in essential arterial hypertension].
Pannier B; Safar M
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():47-51. PubMed ID: 2517009
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of rilmenidine for arterial hypertension.
Beau B; Mahieux F; Paraire M; Laurin S; Brisgand B; Vitou P
Am J Cardiol; 1988 Feb; 61(7):95D-102D. PubMed ID: 2894168
[TBL] [Abstract][Full Text] [Related]
15. [Pharmaco-epidemiologic evaluation of rilmenidine in 18,235 hypertensive patients].
Luccioni R
Presse Med; 1995 Dec; 24(38):1857-64. PubMed ID: 8545441
[TBL] [Abstract][Full Text] [Related]
16. Effort blood pressure control in the course of antihypertensive treatment.
de Divitiis O; Di Somma S; Liguori V; Petitto M; Magnotta C; Ausiello M; Natale N; Brignoli M; Galderisi M
Am J Med; 1989 Sep; 87(3C):46S-56S. PubMed ID: 2782327
[TBL] [Abstract][Full Text] [Related]
17. Dose-effect relationship of rilmenidine after chronic administration.
Luccioni R; Lambert M; Ambrosi P; Scemama M
Eur J Clin Pharmacol; 1993; 45(2):157-60. PubMed ID: 8223838
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of captopril and methyldopa monotherapy for hypertension: double-blind study in Indians.
Tahiliani R; Khokhani RC; Damle VB; Dadkar VN; Jaguste VS; Patel K; Raghu CN; Oke VG
Clin Ther; 1986; 8(5):482-9. PubMed ID: 3533264
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of rilmenidine in elderly patients--comparison with hydrochlorothiazide. The Belgian Multicentre Study Group.
Pelemans W; Verhaeghe J; Creytens G; Coupez G; Van Dessel A; Opsomer M; Corcoran C
Am J Cardiol; 1994 Dec; 74(13):51A-57A. PubMed ID: 7998586
[TBL] [Abstract][Full Text] [Related]
20. Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe.
Stein CM; Neill P; Mwaluko GM; Kusema T
S Afr Med J; 1990 Mar; 77(5):243-5. PubMed ID: 2107581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
